Plasma DOPA levels and growth hormone response to levodopa in parkinsomism
- PMID: 864480
- PMCID: PMC492632
- DOI: 10.1136/jnnp.40.2.162
Plasma DOPA levels and growth hormone response to levodopa in parkinsomism
Abstract
It has been suggested that the therapeutic response to levodopa in patients with Parkinson's disease may be related to changes in plasma growth hormone concentration. In order to examine this problem, we have determined plasma DOPA and growth hormone levels after a standard oral levodopa load in 32 patients with Parkinson's disease. Levodopa caused an increase in plasma growth hormone concentration in 30 subjects. The magnitude and timing of this growth hormone response was not related to the clinical response, the presence or absence of response swings, or the occurrence of dyskinesias. The growth hormone response to levodopa is normal in patients with Parkinson's disease and not altered by long-term levodopa treatment.
Similar articles
-
Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms.Neurology. 1979 Feb;29(2):194-200. doi: 10.1212/wnl.29.2.194. Neurology. 1979. PMID: 571063
-
[Long-term problems of levodopa therapy in Parkinson disease].Schweiz Med Wochenschr. 1987 Mar 7;117(10):347-53. Schweiz Med Wochenschr. 1987. PMID: 3105050 German.
-
Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms.Neurology. 1993 Aug;43(8):1551-5. doi: 10.1212/wnl.43.8.1551. Neurology. 1993. PMID: 8043043
-
Levodopa in the early treatment of Parkinson's disease.Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S17-20. doi: 10.1016/S1353-8020(09)70006-9. Parkinsonism Relat Disord. 2009. PMID: 19131036 Review.
-
Treatment of Parkinson's disease: levodopa as the first choice.J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4. J Neurol. 2002. PMID: 12375059 Review.
Cited by
-
Endocrine aspects of bromocriptine therapy in Parkinsonism.J Neural Transm. 1978;43(2):153-60. doi: 10.1007/BF01579074. J Neural Transm. 1978. PMID: 104006
-
Growth hormone secretion in empty sella syndrome.J Endocrinol Invest. 1982 Nov-Dec;5(6):417-22. doi: 10.1007/BF03350543. J Endocrinol Invest. 1982. PMID: 6763056
-
Bromocriptine in the treatment of parkinsonism.Drugs. 1979 May;17(5):365-82. doi: 10.2165/00003495-197917050-00006. Drugs. 1979. PMID: 37066 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources